60 Degrees Pharmaceuticals Files 2024 Annual Report
Ticker: SXTPW · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1946563
| Field | Detail |
|---|---|
| Company | 60 Degrees Pharmaceuticals, Inc. (SXTPW) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
60 Degrees Pharma filed its 2024 10-K. Check financials.
AI Summary
60 Degrees Pharmaceuticals, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware, is involved in pharmaceutical preparations. Its principal executive offices are located at 1025 Connecticut Avenue NW, Suite 1000, Washington, D.C. 20036, with a business phone number of (202) 327-5422.
Why It Matters
This filing provides investors and the public with a comprehensive overview of 60 Degrees Pharmaceuticals' financial performance and business operations for the past fiscal year.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain specific new risk disclosures beyond what is typical for a 10-K.
Key Players & Entities
- 60 DEGREES PHARMACEUTICALS, INC. (company) — Registrant
- 20241231 (date) — Fiscal Year End
- 20250327 (date) — Filing Date
- 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 (address) — Principal Executive Offices
- 202-327-5422 (phone_number) — Business Phone
FAQ
What is the company's Central Index Key (CIK)?
The CIK for 60 Degrees Pharmaceuticals, Inc. is 0001946563.
In which state was 60 Degrees Pharmaceuticals, Inc. incorporated?
The company was incorporated in Delaware.
What is the Standard Industrial Classification (SIC) code for this company?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for 60 Degrees Pharmaceuticals, Inc.?
The SEC file number is 001-41719.
When was the 10-K filing submitted to the SEC?
The filing was submitted on March 27, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding 60 DEGREES PHARMACEUTICALS, INC. (SXTPW).